Lotus Pharmaceutical Co., Ltd. (TPE:1795)
210.00
-3.00 (-1.41%)
Apr 24, 2025, 1:35 PM CST
Lotus Pharmaceutical Revenue
In the year 2024, Lotus Pharmaceutical had annual revenue of 18.58B TWD with 9.59% growth. Lotus Pharmaceutical had revenue of 4.41B in the quarter ending December 31, 2024, with 28.95% growth.
Revenue
18.58B
Revenue Growth
+9.59%
P/S Ratio
3.00
Revenue / Employee
16.91M
Employees
1,099
Market Cap
55.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18.58B | 1.63B | 9.59% |
Dec 31, 2023 | 16.96B | 2.33B | 15.89% |
Dec 31, 2022 | 14.63B | 1.98B | 15.68% |
Dec 31, 2021 | 12.65B | 1.92B | 17.90% |
Dec 31, 2020 | 10.73B | 1.12B | 11.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.82B |
Lumosa Therapeutics | 39.15M |
Center Laboratories | 1.62B |